• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型胶原蛋白老化增加表皮生长因子受体(EGFR)的表达和激活,并在三维基质模型中诱导肺癌对厄洛替尼产生耐药性。

Type I Collagen Aging Increases Expression and Activation of EGFR and Induces Resistance to Erlotinib in Lung Carcinoma in 3D Matrix Model.

作者信息

Sarazin Thomas, Collin Guillaume, Buache Emilie, Van Gulick Laurence, Charpentier Céline, Terryn Christine, Morjani Hamid, Saby Charles

机构信息

Université de Reims Champagne-Ardenne, Unité BioSpecT, EA7506, SFR CAP-Santé, UFR de Pharmacie, Reims, France.

Université de Reims Champagne Ardenne, Plate-forme Imagerie Cellulaire et Tissulaire (PICT), Reims, France.

出版信息

Front Oncol. 2020 Sep 10;10:1593. doi: 10.3389/fonc.2020.01593. eCollection 2020.

DOI:10.3389/fonc.2020.01593
PMID:33014812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7511549/
Abstract

Type I collagen is the major structural component of lung stroma. Because of its long half-life, type I collagen undergoes post-translational modifications such as glycation during aging process. These modifications have been shown to impact the structural organization of type I collagen fibers. In the present work we evaluated the impact of collagen aging on lung carcinoma cells response to erlotinib-induced cytotoxicity and apoptosis, and on Epidermal Growth Factor Receptor (EGFR) expression and phosphorylation. To this end, experiments were performed in 2D and 3D matrix models established from type I collagen extracted from adult (10 weeks-old) and old (100 weeks-old) rat's tail tendons. Our results show that old collagen induces a significant increase in EGFR expression and phosphorylation when compared to adult collagen in 3D matrix but not in 2D coating. Such modification was associated to an increase in the IC of erlotinib in the presence of old collagen and a lower sensitivity to drug-induced apoptosis. These data suggest that collagen aging confers resistance to the cytotoxic and apoptotic effects of therapies targeting EGFR kinase function in lung carcinoma. Moreover, our data underline the importance of the 3D matrix environment in this process.

摘要

I型胶原蛋白是肺基质的主要结构成分。由于其半衰期长,I型胶原蛋白在衰老过程中会经历翻译后修饰,如糖基化。这些修饰已被证明会影响I型胶原纤维的结构组织。在本研究中,我们评估了胶原蛋白老化对肺癌细胞对厄洛替尼诱导的细胞毒性和凋亡的反应,以及对表皮生长因子受体(EGFR)表达和磷酸化的影响。为此,我们在从成年(10周龄)和老年(100周龄)大鼠尾腱中提取的I型胶原蛋白建立的二维和三维基质模型中进行了实验。我们的结果表明,与二维包被相比,在三维基质中,与成年胶原蛋白相比,老化胶原蛋白会导致EGFR表达和磷酸化显著增加。这种修饰与在老化胶原蛋白存在下厄洛替尼的IC增加以及对药物诱导的凋亡敏感性降低有关。这些数据表明,胶原蛋白老化赋予肺癌对靶向EGFR激酶功能的治疗的细胞毒性和凋亡作用的抗性。此外,我们的数据强调了三维基质环境在这一过程中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/395607ba9900/fonc-10-01593-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/5ef57f54b845/fonc-10-01593-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/ed87d685630d/fonc-10-01593-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/266248d81aa5/fonc-10-01593-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/f3e79713b20a/fonc-10-01593-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/395607ba9900/fonc-10-01593-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/5ef57f54b845/fonc-10-01593-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/ed87d685630d/fonc-10-01593-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/266248d81aa5/fonc-10-01593-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/f3e79713b20a/fonc-10-01593-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07a/7511549/395607ba9900/fonc-10-01593-g0005.jpg

相似文献

1
Type I Collagen Aging Increases Expression and Activation of EGFR and Induces Resistance to Erlotinib in Lung Carcinoma in 3D Matrix Model.I型胶原蛋白老化增加表皮生长因子受体(EGFR)的表达和激活,并在三维基质模型中诱导肺癌对厄洛替尼产生耐药性。
Front Oncol. 2020 Sep 10;10:1593. doi: 10.3389/fonc.2020.01593. eCollection 2020.
2
The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor.胰岛素样生长因子1受体在具有野生型表皮生长因子受体的肺癌细胞中导致对厄洛替尼产生获得性耐药。
Int J Cancer. 2014 Aug 15;135(4):1002-6. doi: 10.1002/ijc.28737. Epub 2014 Feb 4.
3
Age-related modifications of type I collagen impair DDR1-induced apoptosis in non-invasive breast carcinoma cells.年龄相关的 I 型胶原改变会损害非浸润性乳腺癌细胞中 DDR1 诱导的细胞凋亡。
Cell Adh Migr. 2018;12(4):335-347. doi: 10.1080/19336918.2018.1472182. Epub 2018 Jun 28.
4
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.酪氨酸1068磷酸化的表皮生长因子受体(EGFR)在野生型EGFR肺癌临床前模型中可预测厄洛替尼对癌症干细胞的靶向作用。
Cell Death Dis. 2015 Aug 6;6(8):e1850. doi: 10.1038/cddis.2015.217.
5
Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.外源性恢复TUSC2表达通过特定背景途径诱导野生型表皮生长因子受体(EGFR)肺癌细胞对厄洛替尼产生反应,从而提高治疗效果。
PLoS One. 2015 Jun 8;10(6):e0123967. doi: 10.1371/journal.pone.0123967. eCollection 2015.
6
Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK.厄洛替尼通过线粒体氧化磷酸化依赖性激活BAX和BAK,诱导具有表皮生长因子受体L858R突变的人H3255非小细胞肺癌细胞发生线粒体介导的凋亡。
Mol Pharmacol. 2008 Sep;74(3):793-806. doi: 10.1124/mol.107.044396. Epub 2008 Jun 4.
7
Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model.在非小细胞肺癌异种移植模型中,尼古丁通过α1烟碱型乙酰胆碱受体(α 1 nAChR)与表皮生长因子受体(EGFR)之间的相互作用诱导对厄洛替尼的耐药性。
Lung Cancer. 2015 Apr;88(1):1-8. doi: 10.1016/j.lungcan.2015.01.017. Epub 2015 Jan 25.
8
Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.表皮生长因子受体突变型非小细胞肺癌中厄洛替尼诱导的自噬。
Lung Cancer. 2013 Sep;81(3):354-361. doi: 10.1016/j.lungcan.2013.05.012. Epub 2013 Jun 13.
9
CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation.CIP2A介导无EGFR突变的非小细胞肺癌细胞中厄洛替尼诱导的细胞凋亡。
Lung Cancer. 2014 Aug;85(2):152-60. doi: 10.1016/j.lungcan.2014.05.024. Epub 2014 Jun 5.
10
Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion.仅含BH3结构域的促凋亡BCL-2家族蛋白BIM将表皮生长因子受体抑制引发的死亡信号与线粒体相连。
Cancer Res. 2007 Dec 15;67(24):11867-75. doi: 10.1158/0008-5472.CAN-07-1961.

引用本文的文献

1
The collagen matrix regulates the survival and function of pancreatic islets.胶原蛋白基质调节胰岛的存活和功能。
Endocrine. 2024 Mar;83(3):537-547. doi: 10.1007/s12020-023-03592-4. Epub 2023 Nov 24.
2
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers.了解胶质母细胞瘤的信号传导、异质性、侵袭性和药物递送障碍。
Int J Mol Sci. 2023 Sep 19;24(18):14256. doi: 10.3390/ijms241814256.
3
Role of Collagen in Airway Mechanics.胶原蛋白在气道力学中的作用。

本文引用的文献

1
DDR1 and MT1-MMP Expression Levels Are Determinant for Triggering BIK-Mediated Apoptosis by 3D Type I Collagen Matrix in Invasive Basal-Like Breast Carcinoma Cells.DDR1和MT1-MMP的表达水平是侵袭性基底样乳腺癌细胞中三维I型胶原基质触发BIK介导的细胞凋亡的决定因素。
Front Pharmacol. 2019 May 3;10:462. doi: 10.3389/fphar.2019.00462. eCollection 2019.
2
Age-related changes in molecular organization of type I collagen in tendon as probed by polarized SHG and Raman microspectroscopy.运用偏振 SHG 和拉曼微光谱技术研究肌腱中 I 型胶原的分子组织随年龄的变化。
Sci Rep. 2019 May 13;9(1):7280. doi: 10.1038/s41598-019-43636-2.
3
Bioengineering (Basel). 2021 Jan 16;8(1):13. doi: 10.3390/bioengineering8010013.
Global Epidemiology of Lung Cancer.
全球肺癌流行病学。
Ann Glob Health. 2019 Jan 22;85(1):8. doi: 10.5334/aogh.2419.
4
Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy.肿瘤基质力学协调氨基酸可用性以维持肿瘤生长和恶性。
Cell Metab. 2019 Jan 8;29(1):124-140.e10. doi: 10.1016/j.cmet.2018.09.012. Epub 2018 Oct 4.
5
Age-related modifications of type I collagen impair DDR1-induced apoptosis in non-invasive breast carcinoma cells.年龄相关的 I 型胶原改变会损害非浸润性乳腺癌细胞中 DDR1 诱导的细胞凋亡。
Cell Adh Migr. 2018;12(4):335-347. doi: 10.1080/19336918.2018.1472182. Epub 2018 Jun 28.
6
Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas.YAP 表达增强导致肺腺癌对 EGFR TKI 产生耐药性。
Sci Rep. 2018 Jan 10;8(1):271. doi: 10.1038/s41598-017-18527-z.
7
Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance.T790M 阳性非小细胞肺癌中的第三代表皮生长因子受体-酪氨酸激酶抑制剂:耐药新机制综述
Transl Lung Cancer Res. 2016 Dec;5(6):695-708. doi: 10.21037/tlcr.2016.12.02.
8
Erlotinib induces the human non-small-cell lung cancer cells apoptosis via activating ROS-dependent JNK pathways.厄洛替尼通过激活依赖活性氧的JNK信号通路诱导人非小细胞肺癌细胞凋亡。
Cancer Med. 2016 Nov;5(11):3166-3175. doi: 10.1002/cam4.881. Epub 2016 Oct 10.
9
Type I collagen aging impairs discoidin domain receptor 2-mediated tumor cell growth suppression.I型胶原蛋白老化会损害盘状结构域受体2介导的肿瘤细胞生长抑制作用。
Oncotarget. 2016 May 3;7(18):24908-27. doi: 10.18632/oncotarget.8795.
10
The Global Burden of Cancer 2013.《2013 年全球癌症负担》。
JAMA Oncol. 2015 Jul;1(4):505-27. doi: 10.1001/jamaoncol.2015.0735.